Figures & data
Figure 1. Study period. DRSP/EE = drospirenone/ethinyl estradiol Rx = prescription.
Figure 2. Subject disposition. *Drug class samples are not mutually exclusive.
Table 1. Baseline demographics and characteristics.
Figure 3. Mean (A) drug, (B) medical, and (C) total (drug plus medical) costs before and after initiation of DRSP/EE-24/4 therapy. *p < 0.0001 vs pre-index; **p = 0.01 vs pre-index.
Table 2. Mean total (drug plus medical) acne-related treatment costs before and after initiation of DRSP/EE-24/4.
Figure 4. Mean (A) number of days on acne treatment and (B) medication possession ratio (MPR) before and after initiation of drospirenone/ethinyl estradiol 24/4 therapy; *p < 0.0001 vs pre-index; **p = 0.001 vs pre-index. A woman may have received >1 class of acne medication during the study period; therefore, women may be included in ≥1 acne treatment category.
